![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF |
| Inflammatory Bowel Diseases |
|
Free Subscription
4 Aliment Pharmacol Ther |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Inflammatory Bowel Diseases is free of charge.
Letter: Clarifying the Interpretation of Dialysis Risk in Inflammatory Bowel
Disease.
Aliment Pharmacol Ther. 2026 Aug 12. doi: 10.1111/apt.70908.
PubMed
Impact of Prior Biologic Mechanism of Action on Anti-TNF Effectiveness in
Inflammatory Bowel Disease: An ENEIDA Registry Study.
Aliment Pharmacol Ther. 2026 Aug 12. doi: 10.1111/apt.70904.
PubMed
Abstract available
Letter on "Inflammatory Bowel Disease Is Associated With an Increased Risk of
End-Stage Renal Disease: A Population-Based Cohort Study".
Aliment Pharmacol Ther. 2026 Aug 10. doi: 10.1111/apt.70916.
PubMed
Letter: From End-Stage Renal Disease Association to Risk-Stratified Kidney
Surveillance in Inflammatory Bowel Disease.
Aliment Pharmacol Ther. 2026 Aug 9. doi: 10.1111/apt.70909.
PubMed
Inflammatory Bowel Disease.
Ann Intern Med. 2026 Aug 11. doi: 10.7326/ANNALS-26-02511.
PubMed
Abstract available
Effects of Age on Inflammatory Bowel Disease Presentation and Management in Older
Adults.
Dig Dis Sci. 2026 Aug 9. doi: 10.1007/s10620-026-10161.
PubMed
Abstract available
Neutralising autoantibodies against IL-10 and HLA-DRB1*01:03 in paediatric
patients with inflammatory bowel disease.
Gut. 2026 Aug 11:gutjnl-2026-339329. doi: 10.1136/gutjnl-2026-339329.
PubMed
Abstract available
Beyond calprotectin: where leucine-rich alpha2-glycoprotein may fit in small bowel
Crohn disease monitoring.
Inflamm Bowel Dis. 2026 Aug 12:izag165. doi: 10.1093.
PubMed
Prior adalimumab exposure alters infliximab pharmacokinetics and trough targets
in pediatric Crohn's disease.
Inflamm Bowel Dis. 2026 Aug 12:izag146. doi: 10.1093.
PubMed
Abstract available
Clinical outcomes following switch from risankizumab to guselkumab in Crohn's
disease.
J Crohns Colitis. 2026;20:jjag119.
PubMed
Longitudinal transcriptomic analysis of mucosa in ulcerative colitis after
anti-tumor necrosis factor withdrawal compared to continued treatment.
J Crohns Colitis. 2026;20:jjag121.
PubMed
Abstract available
Characterization of remission levels in patients with ulcerative colitis treated
with 5-aminosalicylates: results of the cross-sectional CARUC-ASA study by the
Belgian IBD Research and Development Group.
J Crohns Colitis. 2026;20:jjag100.
PubMed
Abstract available
The trajectory of inflammatory bowel disease in east and southeast Asia:
transitioning from acceleration in incidence to compounding prevalence.
Lancet Gastroenterol Hepatol. 2026 Aug 12:S2468-1253(26)00162.
PubMed
Abstract available
Molecular regulatory mechanism of TRPV4-mediated calcium-dependent 5-HT secretion
from enterochromaffin cells and its involvement in ulcerative colitis.
PLoS One. 2026;21:e0355169.
PubMed
Abstract available
Apoptosis-related genes bridge inflammatory bowel disease and osteoporosis: A
bioinformatic analysis.
PLoS One. 2026;21:e0356002.
PubMed
Abstract available
Thank you for your interest in scientific medicine.